Evidence map›Paper›PMID 16474151›Full record

ArticleJournal of virology2006

Ataxia-telangiectasia-mutated (ATM) protein can enhance human immunodeficiency virus type 1 replication by stimulating Rev function.

Yasuo Ariumi, Didier Trono

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. HIV-1 Vpr and p21 restrict LINE-1 mobility.Nucleic acids research · 2018
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Distinct DDX DEAD-box RNA helicases cooperate to modulate the HIV-1 Rev function.Biochemical and biophysical research communications · 2013
    Article
  11. Article
  12. Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Yasuo AriumiDepartment of Microbiology and Molecular Medicine, University of Geneva, Switzerland.
Didier Trono
Kumamoto University · JPUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ataxia-telangiectasia-mutated (ATM) kinase plays a central role in responses to various forms of DNA damage and has been suggested to facilitate human immunodeficiency virus type 1 (HIV-1) integration. Here, we describe a series of experiences that indicate that ATM can enhance HIV-1 replication by stimulating the action of the Rev viral posttranscriptional regulator. The Rev-dependent stimulation of viral late gene expression was observed with ATM-overexpressing cells, a result confirmed with a Rev-dependent reporter construct. Both parameters were also enhanced upon treatment of HeLa cells with caffeine, a xanthine that, in this cellular context, stimulates ATM activity. As well, decreased levels of virions with reduced infectivity were released by ATM knockdown cells. Notably, ATM overexpression did not stimulate the HIV-1 late gene expression within the context of Rev-independent constructs or the Rex-dependent production of capsid from human T-cell leukemia virus type 1 proviral constructs. Altogether, these results indicate that ATM can positively influence HIV-1 Rev function.

Indexed as

Gene Expression Regulation, ViralVirus ReplicationAtaxia Telangiectasia Mutated ProteinsCaffeineCell Cycle ProteinsCell LineDNA-Binding ProteinsGene Products, revGene SilencingGenes, ReporterHIV-1HIV Core Protein p24HumansLuciferasesProtein Serine-Threonine Kinasesrev Gene Products, Human Immunodeficiency VirusAtaxia Telangiectasia Mutated ProteinsATM protein, humanCaffeineCell Cycle ProteinsDNA-Binding ProteinsGene Products, revHIV Core Protein p24LuciferasesProtein Serine-Threonine Kinasesrev Gene Products, Human Immunodeficiency VirusTumor Suppressor Proteins

Identifiers

PMID16474151
PMCPMC1395391
OpenAlexW2145647602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.